Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilia Falkowska

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vaccine|February 23, 2011
Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in miceMarloes A Naarding, Emilia Falkowska, Hui Xiao, et al.
Journal of Virology|May 18, 2007
Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralizationEmilia Falkowska, Francis Kajumo, Edie Garcia, et al.
Plos One|December 7, 2013
Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity dataAndrew L Ferguson, Emilia Falkowska, Laura M Walker, et al.
Mabs|March 29, 2012
IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CAJohan Nilvebrant, D Cameron Dunlop, Aroop Sircar, et al.
The Journal of General Virology|August 9, 2006
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticlesEmilia Falkowska, Robert J Durso, Jason P Gardner, et al.
Journal of Virology|February 21, 2012
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4Emilia Falkowska, Alejandra Ramos, Yu Feng, et al.
Plos Pathogens|August 13, 2015
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal AntibodiesLaura E McCoy, Emilia Falkowska, Katie J Doores, et al.
Immunity|April 29, 2014
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimersClaudia Blattner, Jeong Hyun Lee, Kwinten Sliepen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2012
Anti-HIV B Cell lines as candidate vaccine biosensorsTakayuki Ota, Colleen Doyle-Cooper, Anthony B Cooper, et al.
Nature|August 19, 2011
Broad neutralization coverage of HIV by multiple highly potent antibodiesLaura M Walker, Michael Huber, Katie J Doores, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vaccine|February 23, 2011
Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in miceMarloes A Naarding, Emilia Falkowska, Hui Xiao, et al.
Journal of Virology|May 18, 2007
Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralizationEmilia Falkowska, Francis Kajumo, Edie Garcia, et al.
Plos One|December 7, 2013
Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity dataAndrew L Ferguson, Emilia Falkowska, Laura M Walker, et al.
Mabs|March 29, 2012
IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CAJohan Nilvebrant, D Cameron Dunlop, Aroop Sircar, et al.
The Journal of General Virology|August 9, 2006
L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticlesEmilia Falkowska, Robert J Durso, Jason P Gardner, et al.
Journal of Virology|February 21, 2012
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4Emilia Falkowska, Alejandra Ramos, Yu Feng, et al.
Plos Pathogens|August 13, 2015
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal AntibodiesLaura E McCoy, Emilia Falkowska, Katie J Doores, et al.
Immunity|April 29, 2014
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimersClaudia Blattner, Jeong Hyun Lee, Kwinten Sliepen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2012
Anti-HIV B Cell lines as candidate vaccine biosensorsTakayuki Ota, Colleen Doyle-Cooper, Anthony B Cooper, et al.
Nature|August 19, 2011
Broad neutralization coverage of HIV by multiple highly potent antibodiesLaura M Walker, Michael Huber, Katie J Doores, et al.
Pageof 2